Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to HEIMBERGER, AMY B
Item TypeName
Academic Article The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.
Academic Article EGFRvIII-targeted vaccination therapy of malignant glioma.
Academic Article Clinical applications of a peptide-based vaccine for glioblastoma.
Academic Article Glioma-associated cancer-initiating cells induce immunosuppression.
Academic Article The natural history of EGFR and EGFRvIII in glioblastoma patients.
Academic Article Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.
Academic Article Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.
Academic Article Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.
Academic Article A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.
Academic Article Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study.
Academic Article Topotecan enhances immune clearance of gliomas.
Academic Article Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.
Academic Article Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.
Academic Article An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.
Academic Article Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.
Academic Article Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?
Academic Article Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
Academic Article BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.
Academic Article Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.
Academic Article Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.
Academic Article Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.
Academic Article Hypoxia potentiates glioma-mediated immunosuppression.
Academic Article Consensus on the role of human cytomegalovirus in glioblastoma.
Concept Glioblastoma
Academic Article miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.
Academic Article Mesenchymal differentiation mediated by NF-?B promotes radiation resistance in glioblastoma.
Academic Article Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.
Academic Article Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
Academic Article Immunotherapy for primary brain tumors: no longer a matter of privilege.
Academic Article A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
Academic Article FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
Academic Article The role of STAT3 in tumor-mediated immune suppression.
Academic Article FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.
Academic Article Immunosuppressive mechanisms in glioblastoma.
Academic Article Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor.
Academic Article Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.
Academic Article Serum microRNA profiling in patients with glioblastoma: a survival analysis.
Academic Article PD-L1 expression and prognostic impact in glioblastoma
Academic Article Cytomegalovirus-targeted immunotherapy and glioblastoma
Academic Article The natural history of EGFR and EGFRvIII in glioblastoma patients
Academic Article Prioritization schema for immunotherapy clinical trials in glioblastoma
Academic Article A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma
Academic Article Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma.
Academic Article Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.
Academic Article Identification of metabolites in plasma for predicting survival in glioblastoma.
Academic Article miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.
Academic Article The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.
Academic Article PD-L1 expression and prognostic impact in glioblastoma.
Academic Article Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?
Academic Article Immunotherapy in glioblastoma: emerging options in precision medicine.
Academic Article GBM-associated mutations and altered protein expression are more common in young patients.
Academic Article Prioritization schema for immunotherapy clinical trials in glioblastoma.
Academic Article Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells.
Academic Article Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.
Academic Article Tumor Vaccines for Malignant Gliomas.
Academic Article Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Academic Article Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.
Academic Article Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.
Academic Article Comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma".
Academic Article Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.
Academic Article Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
Academic Article Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas.
Academic Article FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation.
Academic Article Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes.
Academic Article Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment.
Academic Article Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.
Academic Article Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
Academic Article Are radiation and response biomarkers the missing elements for efficacious immunotherapy for glioma patients?
Academic Article Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.
Academic Article Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
Academic Article Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.
Academic Article Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
Academic Article Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.
Academic Article MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme.
Academic Article Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Academic Article A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.
Academic Article The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma.
Academic Article Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme.
Academic Article A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.
Academic Article Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms.
Academic Article Targeting the av integrin/TGF-? axis improves natural killer cell function against glioblastoma stem cells.
Academic Article Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.
Academic Article Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma.
Academic Article Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment.
Academic Article Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma.
Academic Article New Approaches to Glioblastoma.
Academic Article The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia.
Academic Article ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Academic Article Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Academic Article Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression.
Academic Article Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.
Academic Article A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.
Academic Article A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology.
Academic Article Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma.
Academic Article Immune landscape of a genetically engineered murine model of glioma compared with human glioma.
Academic Article Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era.
Academic Article Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment.
Academic Article Next Steps for Immunotherapy in Glioblastoma.
Academic Article CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.
Academic Article Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease.
Academic Article Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy.
Academic Article FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.
Academic Article Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade.
Academic Article Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma.
Academic Article NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
Academic Article Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma.
Academic Article Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
Search Criteria
  • Glioblastoma